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Iridium(I)-catalyzed Regioselective C-H Activation and Hydrogen 
Isotope Exchange of Non-aromatic Unsaturated Functionality
** 
William J. Kerr,*[a] Richard J. Mudd,[a] Laura C. Paterson,[a] and Jack A. Brown[b] 
 
Abstract: Isotopic labeling is a key technology of increasing 
importance for the investigation of new C-H activation and 
functionalization techniques, as well as in the construction of labeled 
molecules for use within both organic synthesis and drug discovery. 
Herein, we report, for the first time, selective iridium-catalyzed C-H 
activation and hydrogen isotope exchange at the E-position of 
unsaturated organic compounds. The use of our highly active 
[Ir[COD](IMes)(PPh3)]PF6 catalyst, under mild reaction conditions, 
allows the regioselective E-activation and labeling of a range of D,E-
unsaturated compounds with differing steric and electronic 
properties. This novel process delivers high levels of isotope 
incorporation over short reaction times, using low levels of catalyst 
loading. 
The functionalization of aromatic C-H bonds via transition metal-
mediated C-H activation has been widely developed in the past 
several decades, delivering key compounds for use in an array 
of chemical domains.[1] In contrast, regioselective activation of 
olefinic C-H bonds has received much less attention, with the 
majority of studies to date focussed upon the application of 
homogeneous organometallic complexes of ruthenium[2] and 
rhodium.[3] Indeed, very little knowledge exists surrounding the 
use of iridium-based complexes in this area,[4] despite their 
widespread activity in aromatic C-H bond activation.[1a,b,h,k,o] In 
relation to this, transition metal-mediated hydrogen isotope 
exchange (HIE) is a technique of increasing importance, often 
being used as a first step in creating new C-H activation 
methods and as a means to generate deuterated feed stocks for 
mechanistic studies.[5] Furthermore and importantly for medicinal 
chemists, such direct and flexible labeling processes now 
represent a central tool for fast and efficient incorporation of a 
tracer into drug candidates, enabling various metabolic, stability, 
and toxicity studies to be performed earlier in the drug design 
process.[5a,6] Recent studies from our own laboratory[7] have 
disclosed a series of highly active iridium(I) catalysts of the type 
[Ir[COD](IMes)(PR3)]X capable of delivering heavy isotopes of 
hydrogen (deuterium and tritium) to aromatic molecules via an 
ortho-directed C-H insertion process under mild conditions 
(Scheme 1). Indeed, our developed methods have enabled 
access to a broad spectrum of labeled new chemical entities of 
direct relevance to pharmaceutical partners and have provided a 
platform for on-going C-H activation endeavors. Expanding on 
our initial developments, we now report the first example of 
selective C-H activation and hydrogen isotope exchange at the 
E-position of a range of D,E-unsaturated moieties, extending the 
applicability of our emerging catalyst series and addressing the 




Scheme 1. Previous and proposed labeling procedure. 
Our initial studies involved the application of conditions 
developed in our laboratory for the isotopic labeling of aromatic 
substrates.[7a] As such, (E)-4-phenylbutenone, 6a, was treated 
with just 0.5 mol% of our iridium catalyst series (5a-c) in DCM 
and exposed to 1 atm. of D2 gas (Table 1, Entries 1-3).
[9] As 
expected, and based on the differing steric properties of our 
series of catalysts, varying results were obtained. Catalyst 5a, 
bearing the smallest (PMe2Ph) phosphine ligand, produced 
solely the reduced product 8a with quantitative conversion (Entry 
1), with this result being somewhat expected due to our recent 
disclosure that such iridium complexes can act as extremely 
efficient hydrogenation catalysts.[10] Catalyst 5b, containing the 
bulky yet flexible tribenzylphosphine ligand, showed high levels 
of deuterium incorporation, albeit with 8a remaining as the major 
product (Entry 2). Pleasingly, a switch in selectivity was 
observed when moving to the most rigid of our catalyst range 
(5c), whereby the high level of deuterium incorporation was 
maintained and appreciable selectivity for the desired labeled 
compound was achieved (Entry 3). UQWLO UHFHQWO\ &UDEWUHH¶V
catalyst, 5d,[11] was the most widely adopted species in the 
domain of iridium-catalyzed, ortho-directed HIE in aromatic 
compounds, despite the regular necessity for stoichiometric 
loadings.[12] In this study, &UDEWUHH¶V FDWDO\VW (5d) displayed a 
similar level of deuterium incorporation to 5c, however, with 
virtually no selectivity for HIE versus reduction (Entry 4). On  
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1 IMes, P(Me)2Ph 5a 0% 0:100 
2 IMes, PBn3 5b 86% 6:94 
3 IMes, PPh3 5c 95% 77:23 
4 Py, PCy3 5d 96% 46:54 
5
[c] 
IMes, PPh3 5c 88% 94:6 
6
[d] 
IMes, PPh3 5c 78% 99:1 
[a] Each entry displays the average of two reaction runs. [b] Calculated from 
the NMR spectra of crude reaction material. [c] 6a (0.4 mmol), DCM (8 mL), 
5c (0.1 mol%). [d] 6a (0.4 mmol), DCM (1 mL), 5c (0.1 mol%). 
 
further optimization of the reaction conditions using catalyst 5c, 
we were delighted to observe that a reduction in catalyst loading 
to 0.1 mol% resulted in an excellent selectivity of 94:6 for the 
desired E-labeled enone product, 7a, whilst maintaining high D 
incorporation levels (Entry 5). Furthermore, increasing the 
concentration of the reaction delivered 7a almost exclusively 
with 78% D labeling (Entry 6).  
With conditions in hand that produce appreciable 
selectivity for E-C-H activation and hydrogen isotope exchange, 
we looked to further explore the capabilities of our developed 
system by extending the substrate scope (Table 2). In this 
regard, our initial focus was directed towards the manipulation of 
the chemical properties of the arene component present in 6. 
We were pleased to find that substituents of varying electronic 
properties were tolerated well at the 4-position of the arene 
substrate, with high levels of deuterium incorporation and very 
good selectivities being achieved using just 0.1 mol% catalyst 
loading in all cases (7b-g). Further to this, steric encumbrance 
adjacent to the labeling position was investigated as in 6h and 6i. 
Encouragingly, meta-substituted compound 6h did not hinder 
appreciably the HIE process, however, a drop in deuterium 
incorporation was observed upon labeling ortho-substituted 
analogue 6i, presumably due to an unfavorable steric interaction 
between the catalyst and the ortho-substituted aryl ring, affecting 
the key C-H activation process. On the other hand, the 
pharmaceutically-relevant thiophene derivative 6j displayed high 
incorporation and excellent selectivity. Our studies continued 
with investigations into the nature of the directing group. Notably, 
good incorporation levels were observed in compounds 7k-m 
albeit with slightly diminished selectivity between HIE and 
reduction for 7k and 7l. Presumably this can be attributed to the 
nature of the intermediate formed upon directing group 
coordination and the reversibility of this process; as well as 
facilitating faster decomplexation, we envisage that the larger 
substrates will adopt a less planar conformation upon binding to 
the catalyst, potentially better suited towards the reduction 
pathway. Having stated this, selectivity was restored in 7k 
following employment of an even lower level of catalyst loading 
(0.025 mol%), highlighting the level of activity presented by 
catalyst species 5c for this labeling process. Finally, we were 
also pleased to discover that alternative directing groups such 
as amide or nitro functionalities facilitated the regioselective C-H 
activation and exchange process with appreciable efficiency (6n-
o). Indeed, substrate 6o represents, to the best of our 
knowledge, the first example of a nitro moiety directing such a ȕ-
C-H activation.  
 





[a] Each entry displays the average of two reaction runs and the results 
presented as %D incorporation in 7 with the selectivity of 7:8 shown in 
parentheses. [b] 0.025 mol% of 5c was employed. [c] 0.25 mol% of 5c 
was employed.  
 
In relation to the reaction mechanism, DQG EDVHG RQ +H\V¶
original proposal in 1996,[13] we have recently disclosed 
experimental and computational studies which have led to 
escalated insight into the possible sequence of events that our 
µortho¶-directed HIE process follows.[7d] In this regard, a similar 
process could be envisaged for the olefinic substrates described 
within this contribution (Pathway A, Scheme 2). Following 
catalyst activation with D2, coordination of the substrate, e.g. 6a, 
delivers intermediate 9, where the E-H atom is associated with 
the iridium center via an agostic interaction, consistent with our 
related ortho aryl labelling mechanistic studies.[7d] Subsequent 
oxidative addition delivers 10, followed by hydride fluxionality 
bringing isotopic hydrogen cis to the activated complex as in 11. 
Finally, reductive elimination and decomplexation releases the 






Scheme 2. Possible HIE mechanistic pathways; all intermediates within this process are assumed to be cationic, with the counter being omitted for clarity.  
atmosphere. In contrast, one could also consider that the E-
selective labeling process proceeds in the manner described by 
Pathway B, Scheme 2. In this case, following the same catalyst 
activation sequence to generate 9, the intramolecular delivery of 
a deuteride in a conjugate manner would provide enolate-type 
intermediate 13 (where S = solvent). Following bond rotation to 
give 14, the cycle is completed with hydride abstraction and 
decomplexation. 
To probe these mechanistic proposals, we conducted a 
series of additional experimental studies. Firstly, Hammett 
studies were employed, whereby competition reactions were run 
for the HIE of substrate 6a versus a selected set of four p-
substituted enone substrates (15, Scheme 3). Following 1H NMR 
analysis and construction of the Hammett plot, a relatively small 
negative slope of -0.64 was revealed, indicating that whilst 
electron-donating functionality facilitates an increases in HIE, 
such influence does not occur during the rate determining step 
of the reaction (see Supporting Information for full details).[14] 
This electronic effect can be envisaged as being a result of the 
increased binding ability of the more electron-rich substrates 
with the iridium catalyst; this effect would be observed within 
both pathways A and B. Having stated this, the magnitude of the 
Hammett U value indicates that no significant build-up of charge 
is evident during the rate-limiting step of the overall process and, 
as such, this lends some support to mechanistic pathway A, i.e. 
via insertion intermediate 10 as opposed to the enolate-type 
structure 13 proposed in pathway B. Further, it is important to 
note that both the (Z)-isomer of substrate 6a and cyclohexenone 
fail to label under the developed protocols; we believe that both 
of these latter substrates would be unable to undergo the 
insertion process proposed within mechanistic pathway A (see 
Supporting Information for full experimental details). 
In relation to these preliminary mechanistic investigations, 
further analysis attempted to strengthen our proposals by 
measuring the kinetic isotope effect (KIE) within our developed  
 
Scheme 3. Competition studies for the HIE of 6a versus p-substituted enone 
substrates.  
HIE process. Monitoring the rate of our standard reaction, as 
well as the reverse process (employing H2 in place of D2 with 
fully deuterated 7a), revealed a primary KIE value of 3.8, thus 
strongly indicating that C-H activation is involved in the rate-
limiting step, and in line with pathway A. Indeed, if pathway B 
were to be favoured, one would expect an inverse KIE value if 
conjugate addition was rate determining, or a much larger KIE 
value (5) for hydride abstraction.[15] Notably, the stoichiometric 
isolation of intermediates similar to 10 by Crabtree further 
supports this proposed pathway A.[4c] 
In summary, we have established the first E-selective 
iridium-catalyzed C-H activation and hydrogen isotope exchange 
process using our active iridium(I) catalyst, 
[Ir[COD](IMes)(PPh3)]PF6. Under practically accessible reaction 
conditions, and employing low levels of catalyst loading, very 
good levels of deuterium incorporation have been obtained with 
appreciable selectivity over the potentially competing reduction 
process across a series of D,E-unsaturated substrates. 
Additional experimental studies have enhanced our insight into 
the possible mechanistic pathway being followed, whereby it is 
believed that a C-H activation process is the rate-limiting step of 
the overall transformation. Our work continues within this area to 
fully elucidate the mechanism of these emerging transformations 





selectivity, with the overall aim of applying our developing 
techniques to a wider array of C-H activation processes. 
Keywords: C-H activation  iridium  hydrogen isotope 
exchange  unsaturated compounds  deuterium 
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E-Selective activation with iridium: 
Efficient and selective olefinic C-H 
activation and D labeling is achieved 
by mild iridium catalysis (see 
scheme). 
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